DE3584183D1 - Octahydrothiazolo(4,5-g)chinoline. - Google Patents

Octahydrothiazolo(4,5-g)chinoline.

Info

Publication number
DE3584183D1
DE3584183D1 DE8585302852T DE3584183T DE3584183D1 DE 3584183 D1 DE3584183 D1 DE 3584183D1 DE 8585302852 T DE8585302852 T DE 8585302852T DE 3584183 T DE3584183 T DE 3584183T DE 3584183 D1 DE3584183 D1 DE 3584183D1
Authority
DE
Germany
Prior art keywords
sub
alkyl
octahydrothiazolo
nhc
sup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585302852T
Other languages
English (en)
Inventor
Edmund Carl Kornfeld
Robert Daniel Titus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE3584183D1 publication Critical patent/DE3584183D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/30—Metal salts; Chelates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8585302852T 1984-04-27 1985-04-24 Octahydrothiazolo(4,5-g)chinoline. Expired - Lifetime DE3584183D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/604,687 US4537893A (en) 1984-04-27 1984-04-27 Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors

Publications (1)

Publication Number Publication Date
DE3584183D1 true DE3584183D1 (de) 1991-10-31

Family

ID=24420601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585302852T Expired - Lifetime DE3584183D1 (de) 1984-04-27 1985-04-24 Octahydrothiazolo(4,5-g)chinoline.

Country Status (19)

Country Link
US (1) US4537893A (de)
EP (1) EP0160502B1 (de)
JP (1) JPH0631262B2 (de)
KR (1) KR870001072B1 (de)
CN (1) CN85101547A (de)
AT (1) ATE67767T1 (de)
AU (1) AU564946B2 (de)
CA (1) CA1287356C (de)
DE (1) DE3584183D1 (de)
DK (1) DK185485A (de)
ES (1) ES8704177A1 (de)
GR (1) GR850989B (de)
HU (1) HU193113B (de)
IL (1) IL74988A0 (de)
NZ (1) NZ211863A (de)
PH (1) PH21951A (de)
PT (1) PT80339B (de)
SU (1) SU1414318A3 (de)
ZA (1) ZA852999B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778894A (en) * 1983-09-26 1988-10-18 Eli Lilly And Company 6 oxo-decahydroquinolines
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US5134143A (en) * 1986-06-16 1992-07-28 Eli Lilly And Company BCD tricyclic ergoline part-structure analogues
US4977160A (en) * 1986-06-16 1990-12-11 Eli Lilly And Company BCD tricyclic ergoline part-structure analogues
DE3624607A1 (de) * 1986-07-21 1988-01-28 Boehringer Ingelheim Kg Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US5006525A (en) * 1989-07-24 1991-04-09 Eli Lilly And Company Dopamine agonists method
US5057515A (en) * 1989-07-24 1991-10-15 Eli Lilly And Company Method for agonizing a dopamine receptor
US4939259A (en) * 1989-07-24 1990-07-03 Eli Lilly And Company 2-oxo-pyrido[2,3-g]quinoline derivatives
US4977149A (en) * 1989-07-24 1990-12-11 Eli Lilly And Company Pyridoquinoline dopamine agonists, compositions and use
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
EP0816406B1 (de) * 1996-06-26 2000-09-06 Bayer Ag Verfahren zur Herstellung salzarmer Präparationen von Kondensationsprodukten
CA2724534A1 (en) * 2008-05-14 2009-11-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of somatostatin-dopamine conjugates
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2056224A1 (de) * 1969-11-17 1971-06-03 Danchi Seiyaku Co , Ltd , Tokio Neue Thiazolochinohnderivate und Ver fahren zu ihrer Herstellung
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
US4258049A (en) * 1979-07-02 1981-03-24 Smithkline Corporation Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
US4367231A (en) * 1979-09-14 1983-01-04 Eli Lilly And Company Method of using octahydro pyrazolo[3,4-g]quinolines

Also Published As

Publication number Publication date
DK185485A (da) 1985-10-28
DK185485D0 (da) 1985-04-25
AU564946B2 (en) 1987-09-03
ZA852999B (en) 1986-11-26
EP0160502B1 (de) 1991-09-25
KR850007261A (ko) 1985-12-02
ES542565A0 (es) 1987-03-16
IL74988A0 (en) 1985-08-30
KR870001072B1 (ko) 1987-05-27
JPS60233091A (ja) 1985-11-19
EP0160502A2 (de) 1985-11-06
PH21951A (en) 1988-04-15
SU1414318A3 (ru) 1988-07-30
NZ211863A (en) 1987-10-30
JPH0631262B2 (ja) 1994-04-27
AU4166685A (en) 1985-10-31
CA1287356C (en) 1991-08-06
CN85101547A (zh) 1987-01-24
ATE67767T1 (de) 1991-10-15
HU193113B (en) 1987-08-28
ES8704177A1 (es) 1987-03-16
HUT37624A (en) 1986-01-23
PT80339B (en) 1987-02-16
EP0160502A3 (en) 1987-03-11
PT80339A (en) 1985-05-01
GR850989B (de) 1985-11-25
US4537893A (en) 1985-08-27

Similar Documents

Publication Publication Date Title
DE3584183D1 (de) Octahydrothiazolo(4,5-g)chinoline.
KR850001171A (ko) 퀴놀린 화합물의 제조방법
SE8804586D0 (sv) 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
SE8204237D0 (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
EA199801000A1 (ru) Производные алкиламинобензотиазола и -бензоксазола
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
DK67384D0 (da) N-iminopyridiniumbetainderivater
KR850001213A (ko) 이미다조[1,5-a] 피리미딘 유도체의 제조방법
ES533320A0 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
KR860001815A (ko) 옥타하이드로-옥사졸로[4,5-g]퀴놀린의 제조방법
AU562643B2 (en) N-arylpiperazine derivatives
RU93004729A (ru) Новые производные имидазола
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
YU47949B (sh) 3,4-DI-(HIDRO)-2H,6H-PIRIMIDO (2,1-b)(1,3) TIAZIN DERIVATII1,2,3,4-TETRA-(HIDRO)-PIRIMIDIN.2.TIONI I POSTUPCI ZA NJIHOVO DOBIJANJE
DK165586A (da) Heterocycliske amidderivater, deres fremstilling og anvendelse som fungicider
IT1161216B (it) Composizioni farmaceutiche contenenti composti a scheletro flavanonico, procedimento per la preparazione di detti composti e nuovi composti ottenuti
KR870008884A (ko) 2-아미노 피리미도 [4,5-g] 퀴놀린의 제조 방법
RU95117134A (ru) Производное морфолина или его фармацевтически приемлемая соль и фармацевтическая композиция на его основе
DK0763516T3 (da) Fremstilling og anvendelse af rene enantiomerer af 8-halogen-6-hydroxyoctansyrer, deres alkylestere og deres salte med rene enantiomerer af alfa-methylbenzylamin
ATE30675T1 (de) Benzobicyclononanamin-derivate mit antikonvulsiven eigenschaften.
BR8400237A (pt) Derivados de sulfenil nitrometano,processo para a preparacao de derivados de sulfenil nitrometano,composicoes pesticidas e metodo para combater pragas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee